Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?
Turn Therapeutics, Inc. is a Westlake Village, CA-based biotech company founded in 2015renaissancecapital.com. The company officially rebranded to Turn Therapeutics in Sept 2025 ahead of its Nasdaq listingstockanalysis.com. Turn’s mission is to “turn the tides” in medicine by developing technologies that heal, not just manage, challenging traditional treatmentsbenzinga.com. CEO Bradley Burnam leads a lean operation “built on a shoestring, with an absolute disdain for waste,” as he emphasized during the Nasdaq bell-ringing ceremonybenzinga.com. Burnam and his team bring a “patient-first” approach and a frugal business model to drug development, aiming to maximize R&D output per dollar. The executive leadership also includes CMO Neilesh Ghodadra and directors Abraham Chesed and Andrew Gengosreuters.comreuters.com, who collectively have experience in dermatology, clinical research, and biotech management.
